In this randomized controlled trial, high-dose intravenous vitamin C combined with docetaxel (a chemotherapy drug) did not affect outcomes in men with a certain type of metastatic prostate cancer, compared to treatment with docetaxel alone.
This Study Summary was published on November 7, 2024.
